Correlation Between Aquestive Therapeutics and Amplifon SpA

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aquestive Therapeutics and Amplifon SpA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aquestive Therapeutics and Amplifon SpA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aquestive Therapeutics and Amplifon SpA, you can compare the effects of market volatilities on Aquestive Therapeutics and Amplifon SpA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aquestive Therapeutics with a short position of Amplifon SpA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aquestive Therapeutics and Amplifon SpA.

Diversification Opportunities for Aquestive Therapeutics and Amplifon SpA

0.19
  Correlation Coefficient

Average diversification

The 3 months correlation between Aquestive and Amplifon is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Aquestive Therapeutics and Amplifon SpA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amplifon SpA and Aquestive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aquestive Therapeutics are associated (or correlated) with Amplifon SpA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amplifon SpA has no effect on the direction of Aquestive Therapeutics i.e., Aquestive Therapeutics and Amplifon SpA go up and down completely randomly.

Pair Corralation between Aquestive Therapeutics and Amplifon SpA

Given the investment horizon of 90 days Aquestive Therapeutics is expected to generate 2.48 times more return on investment than Amplifon SpA. However, Aquestive Therapeutics is 2.48 times more volatile than Amplifon SpA. It trades about 0.09 of its potential returns per unit of risk. Amplifon SpA is currently generating about 0.13 per unit of risk. If you would invest  210.00  in Aquestive Therapeutics on September 3, 2024 and sell it today you would earn a total of  299.00  from holding Aquestive Therapeutics or generate 142.38% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy37.25%
ValuesDaily Returns

Aquestive Therapeutics  vs.  Amplifon SpA

 Performance 
       Timeline  
Aquestive Therapeutics 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Aquestive Therapeutics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Aquestive Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.
Amplifon SpA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Amplifon SpA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Amplifon SpA is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Aquestive Therapeutics and Amplifon SpA Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aquestive Therapeutics and Amplifon SpA

The main advantage of trading using opposite Aquestive Therapeutics and Amplifon SpA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aquestive Therapeutics position performs unexpectedly, Amplifon SpA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amplifon SpA will offset losses from the drop in Amplifon SpA's long position.
The idea behind Aquestive Therapeutics and Amplifon SpA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Stocks Directory
Find actively traded stocks across global markets
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio